Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.
The repeated administration of methamphetamine to rats has been shown to cause a long-lasting depletion of dopamine in various brain regions. In the first study, the effects of pretreatment with alphamethyltyrosine (AMT) or reserpine on the long-lasting methamphetamine-induced dopamine depletion were examined. In the second study, the effects of AMT and reserpine on central dopamine levels were measured in rats previously treated with methamphetamine. Pretreatment with AMT attenuated the long-lasting dopamine depletion induced by methamphetamine, whereas, pretreatment with reserpine increased the depletion. The acute effects of AMT and reserpine on brain dopamine were not altered when administered two weeks after the last methamphetamine injection.
D000818:Animals; D002421:Caudate Nucleus / Q000032:analysis / Q000187:drug effects*; D004298:Dopamine / Q000032:analysis*; D004347:Drug Interactions; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage*; D008781:Methyltyrosines / Q000008:administration & dosage*; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000008:administration & dosage*
D008781:Methyltyrosines; D008694:Methamphetamine; C022260:alpha-methyltyrosine methyl ester; D012110:Reserpine; D004298:Dopamine